financial misappropriation ann is out, page-152

GC i dont suggest Novartis would change a successful formula based on nothing, certainly they would have insured it had some benefit or couldnt be bothered one would reasonably assume.

In this day and age though i wonder if 'being seen to be offering something different' in some way from their competitors would justify using this delivery method? Everyone wants to have an advantage to promote over their competition, be in perceived or justified.

ENA and MMA are doing the same thing i imagine by being linked to the science behind POH, but i am assuming their trial results justify an improved performance hence their success to date.

Just a thought, but if i were Novartis i would be doing my own research independent of POH, as they would have done before committing to this...bit like CSL and Nestle who passed on whatever they were looking for it needs to be acknowledged